Xpert MTB/RIF for Rapid Diagnosis of Tuberculous Lymphadenitis from Fine-Needle-Aspiration Biopsy Specimens
Open accessThe DOI matches its Crossref record; 15 of the 16 references it cites were found in a registry or an index; 2 of the 6 sources its claims cite were checked for support.
Abstract
This study demonstrates the excellent diagnostic accuracy of the Xpert MTB/RIF test in patients with tuberculous lymphadenitis. The test sensitivity and specificity were 96.7% (95% confidence interval [CI], 86.6 to 100%) and 88.9% (95% CI, 69.6 to 100%), respectively, and it correctly identified 6/6 (100%) of the cytology smear-negative/culture-positive cases and 1 of 2 (50%) rifampin-resistant cases.
Overview
CoChat Summary
TL;DR
Xpert MTB/RIF showed high diagnostic accuracy for tuberculous lymphadenitis using fine-needle-aspiration biopsy specimens, with rapid results compared with culture. It detected all six smear-negative/culture-positive cases but only one of two rifampin-resistant cases.
Key findings
- Against the composite reference standard, Xpert MTB/RIF sensitivity was 96.7% (29/30; 95% CI, 86.6 to 100%) and specificity was 88.9% (16/18; 95% CI, 69.6 to 100%).
- Xpert MTB/RIF was positive in 6/6 (100%) smear-negative/culture-positive cases and identified 1 of 2 (50%) rifampin-resistant cases.
- Average time to microbiological culture result was 18.5 days (range, 9 to 55 days), whereas Xpert MTB/RIF results were available within 2 h of test commencement.
- Among 48 patients with adequate smears, cytomorphological features associated with TB were seen in 32 (66.7%); HIV status was positive in 9 (18.8%), negative in 3 (6.6%), and unknown in 36 (75%).
Methods
- Diagnostic accuracy study of 50 consenting patients referred for fine-needle aspiration biopsy (FNAB) with possible mycobacterial lymphadenitis; 48 cases had adequate smears for diagnosis and were analyzed.
- FNAB was performed with two passes; smears were used for cytology, Ziehl-Neelsen staining, and Papanicolaou stain-induced fluorescence microscopy. Residual aspirate material was used for MGIT 960 mycobacterial culture, with MTBDRplus genotypic drug susceptibility testing on positive cultures, and the remaining aspirate was processed for Xpert MTB/RIF.
- Performance was calculated using Statistica version 8, comparing Xpert MTB/RIF to a reference standard of positive cytology (cytomorphology consistent with mycobacterial infection plus direct organism visualization) and/or culture positive for *M. tuberculosis*.
Limitations
- The paper states that limitations include the small number of rifampin-resistant cases identified and that the research was conducted in a referral center, whereas the technique is ideally suited to peripheral laboratories.
- Evident from the text: only 48 patients were analyzed, only 2 rifampin-resistant cases were identified, and HIV status was unknown for 36/48 patients (75%).
- Evident from the text: one possible false-negative Xpert result had a prolonged 9-day transit interval before testing, and one false-positive result occurred in an epithelial inclusion cyst with no known explanation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
2 Valid · 0 Not valid · 2 Not checked · 15 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In that study, the combined sensitivity and specificity of 77.3% and 98.2% were reported, respectively.”
What the sources say
- Partly supportedcites [6] matched to “Rapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System” (2011) sourceExperimental — accuracy not yet measured
The Results (Table 2) report 77.3% sensitivity and 98.2% specificity for all extrapulmonary specimen types combined, as the printed citing sentence states. The claim's added restriction to tissue is not supported: Table 2 gives tissue-specific values of 69.0% and 98.4%. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The test sensitivity and specificity were 96.7% (95% confidence interval [CI], 86.6 to 100%) and 88.9% (95% CI, 69.6 to 100%), respectively”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The test sensitivity and specificity were 96.7% (95% confidence interval [CI], 86.6 to 100%) and 88.9% (95% CI, 69.6 to 100%), respectively”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“it correctly identified 6/6 (100%) of the cytology smear-negative/culture-positive cases”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The cytomorphology from one of the false-positive results showed a necrotizing suppurative lymphadenitis, which is consistent with TB.”
plainstates an associationSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
5 more claims
Create a free account to see all 19 claims and every source verdict.
- It may state two separate claims as one. 4
- Probably not a substantial claim. 5
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, the sensitivity of Xpert in the current study is lower than what was found in similar study by Ligthelm et al (sensitivity, 96.7%) [22].”
From GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings (2015) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“The specificity (91%) of the Xpert in the current study was found to be consistent with previous studies reported by others (specificity, 89–99%) [20,21,22], but higher than the study done by Biadigilegn et al (specificity, 69.2%) [13].”
From GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings (2015) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“In agreement with other studies [9,18,22], Xpert has a higher sensitivity than smear microscopy.”
From GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings (2015) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Negative 3 6.6”
Reported 6.6 · recomputed 6.25
Citations
Cites
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309 · cited 2×
“MTB/RIF testing as previously described (2).”
MethodSelf-citationExtrapulmonary tuberculosis: an overview.
Golden, M., & Vikram, H. R. (2005) · PubMed · Cited by 1,033
Boehme, C. C., Nicol, M. P., Nabeta, P., Michael, J. S., Gotuzzo, E., Tahirli, R., Gler, M. T., Blakemore, R., Worodria, W., Gray, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60438-8 · Cited by 1,013
Self-citationHelb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M. R., Rodgers, R., Banada, P., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01463-09 · Cited by 914 · cited 1×
“This represents a substantial reduction in diagnostic delay, thereby permitting real-time decision making and planning of treatment (5).”
BackgroundExtra Pulmonary Tuberculosis: An Overview
J. Cantres-Fonseca, O., Rodriguez-Cintrón, W., Del Olmo-Arroyo, F., & Baez-Corujo, S. (2019) · Role of Microbes in Human Health and Diseases · doi:10.5772/intechopen.81322 · Cited by 514
Extrapulmonary tuberculosis: an overview
Ramírez-Lapausa, M., Menéndez-Saldaña, A., & Noguerado-Asensio, A. (2015) · Cited by 478
Rapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System
Hillemann, D., Rüsch-Gerdes, S., Boehme, C., & Richter, E. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02268-10 · Cited by 413 · cited 2×
“Xpert MTB/RIF has been used successfully on various extrapulmonary specimens, including urine and stool (6), but has not been rigorously evaluated with the use of tissue specimens, such as FNAB specimens.”
BackgroundMethodBarnard, M., Albert, H., Coetzee, G., O'Brien, R., & Bosman, M. E. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1436oc · Cited by 391
Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs
Barrera, L. Y. B., Cooreman, E., Iragena, J. D. D., Drobniewski, F. A., Duda, P. W., Havelková, M., Hoffner, S. E., Km, K., Kim, S. J., Labelle, S., et al. (2008) · Cited by 328
The spectrum of disease in children treated for tuberculosis in a highly endemic area.
Marais, B. J., Gie, R. P., Schaaf, H. S., Hesseling, A. C., Enarson, D. A., & Beyers, N. (2006) · PubMed · Cited by 214
Self-citation
Research works printed but not linked: 1
- LeimanG. 1995. The registered nurse as aspirator: experience in a busy cytopathology unit. Acta Cytol. 39:1010.
Cited by
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart, K. R., Schiller, I., Horne, D. J., Pai, M., Boehme, C. C., & Dendukuri, N. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub3 · Cited by 1,102
Denkinger, C. M., Schumacher, S. G., Boehme, C. C., Dendukuri, N., Pai, M., & Steingart, K. R. (2014) · European Respiratory Journal · doi:10.1183/09031936.00007814 · Cited by 527
Lawn, S. D., Mwaba, P., Bates, M., Piatek, A., Alexander, H., Marais, B. J., Cuevas, L. E., McHugh, T. D., Zijenah, L., Kapata, N., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70008-2 · Cited by 458
Self-citationScaling up interventions to achieve global tuberculosis control: progress and new developments
Raviglione, M., Marais, B., Floyd, K., Lönnroth, K., Getahun, H., Migliori, G. B., Harries, A. D., Nunn, P., Lienhardt, C., Graham, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60727-2 · Cited by 340
Self-citationClinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
Tortoli, E., Russo, C., Piersimoni, C., Mazzola, E., Dal Monte, P., Pascarella, M., Borroni, E., Mondo, A., Piana, F., Scarparo, C., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00176311 · Cited by 322
Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
Horne, D. J., Kohli, M., Zifodya, J. S., Schiller, I., Dendukuri, N., Tollefson, D., Schumacher, S. G., Ochodo, E. A., Pai, M., & Steingart, K. R. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub4 · Cited by 267
“Ligthelm 2011 {published data only} Ligthelm LJ, Nicol MP, Hoek KG, Jacobson R, Van Helden PD, Marais BJ, et al. Xpert MTB/RIF for rapid diagnosis of tuberculous lymphadenitis from fine-needle-aspiration biopsy specimens.”
MethodRapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF
Weyer, K., Mirzayev, F., Migliori, G. B., Van Gemert, W., D'Ambrosio, L., Zignol, M., Floyd, K., Centis, R., Cirillo, D. M., Tortoli, E., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00157212 · Cited by 256
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart, K. R., Sohn, H., Schiller, I., Kloda, L. A., Boehme, C. C., Pai, M., & Dendukuri, N. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub2 · Cited by 253
Xpert ® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
Kohli, M., Schiller, I., Dendukuri, N., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub2 · Cited by 245
Lawn, S. D. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-103 · Cited by 242
“Fine needle aspirates of enlarged lymph nodes and urine samples [25,43,45,46] might also be examined using culture or the Xpert MTB/RIF assay and mycobacterial blood cultures might be done to provide a composite microbiological gold standard.”
MethodMaynard-Smith, L., Larke, N., Peters, J. A., & Lawn, S. D. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0709-7 · Cited by 218
“text review, 55 papers were subsequently excluded, and 31 papers containing data on the diagnostic accuracy of Xpert MTB/RIF for TB when testing non-respiratory samples were reviewed in detail [12-38].”
BackgroundKohli, M., Schiller, I., Dendukuri, N., Yao, M., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub3 · Cited by 215
Zifodya, J. S., Kreniske, J. S., Schiller, I., Kohli, M., Dendukuri, N., Schumacher, S. G., Ochodo, E. A., Haraka, F., Zwerling, A. A., Pai, M., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub5 · Cited by 179
Kay, A. W., Fernández, L. G., Takwoingi, Y., Eisenhut, M., Detjen, A., Steingart, K. R., & Mandalakas, A. M. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013359.pub2 · Cited by 154
Diagnosis of extrapulmonary tuberculosis using the Xpert®MTB/RIF assay
Lawn, S. D., & Zumla, A. I. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.43 · Cited by 127
“Five of the eight studies presented in Table 1 are studies of ‘convenience’, being laboratorybased evaluations of routine samples, whereas just three studies prospectively recruited patients for diagnostic evaluation [10,12].”
BackgroundResultScott, L. E., Beylis, N., Nicol, M., Nkuna, G., Molapo, S., Berrie, L., Duse, A., & Stevens, W. S. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03553-13 · Cited by 114
“Three studies from the region on the performance of Xpert on EPTB specimens have to date focused only on pleural TB (8), TB lymphadenitis (18), and HIV-associated lymph node TB (LNTB) (19) in specific settings.”
BackgroundSelf-citationPandie, S., Peter, J. G., Kerbelker, Z. S., Meldau, R., Theron, G., Govender, U., Ntsekhe, M., Dheda, K., & Mayosi, B. M. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-101 · Cited by 95
“of extra-pulmonary TB such as TB lymphadenitis [23], pleural TB [24], and TB meningitis [25].”
BackgroundLawn, S. D., Dheda, K., Kerkhoff, A. D., Peter, J. G., Dorman, S., Boehme, C. C., & Nicol, M. P. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-407 · Cited by 90
“Additional extrapulmonary samples such mycobacterial blood cultures [28] or fine needle lymph node aspirates [29,30] might also be obtained for culture or Xpert MTB/RIF testing.”
BackgroundSelf-citationTadesse, M., Abebe, G., Abdissa, K., Aragaw, D., Abdella, K., Bekele, A., Bezabih, M., Apers, L., de Jong, B. C., & Rigouts, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137471 · Cited by 85
“The specificity (91%) of the Xpert in the current study was found to be consistent with previous studies reported by others (specificity, 89–99%) [20,21,22], but higher than the study done by Biadigilegn et al (specificity, 69.”
ResultDiagnosis and treatment of paediatric tuberculosis: An insight review
Mandal, N., Anand, P. K., Gautam, S., Das, S., & Hussain, T. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2016.1262813 · Cited by 93
Sharma, S. K., Kohli, M., Chaubey, J., Yadav, R. N., Sharma, R., Singh, B. K., Sreenivas, V., Sharma, A., Bhatia, R., Jain, D., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00059014 · Cited by 78
Balcha, T. T., Sturegård, E., Winqvist, N., Skogmar, S., Reepalu, A., Jemal, Z. H., Tibesso, G., Schön, T., & Björkman, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085478 · Cited by 71
“Good diagnostic performance has also been shown for TB lymphadenitis [21].”
Singh, U. B., Pandey, P., Mehta, G., Bhatnagar, A. K., Mohan, A., Goyal, V., Ahuja, V., Ramachandran, R., Sachdeva, K. S., & Samantaray, J. C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149258 · Cited by 68
New Diagnostics for Childhood Tuberculosis
Chiang, S. S., Swanson, D. S., & Starke, J. R. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.05.011 · Cited by 62
Dhasmana, D. J., Ross, C., Bradley, C. J., Connell, D. W., George, P. M., Singanayagam, A., Jepson, A., Craig, C., Wright, C., Molyneaux, P. L., et al. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201308-250oc · Cited by 57
Self-citationHIV and tuberculosis – science and implementation to turn the tide and reduce deaths
Harries, A. D., Lawn, S. D., Getahun, H., Zachariah, R., & Havlir, D. V. (2012) · Journal of the International AIDS Society · doi:10.7448/ias.15.2.17396 · Cited by 54
Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa
Lawn, S. D., Harries, A. D., Meintjes, G., Getahun, H., Havlir, D. V., & Wood, R. (2012) · AIDS · doi:10.1097/qad.0b013e3283565dd1 · Cited by 55
“Testing fine needle aspirates of lymph nodes and other extrapulmonary clinical samples using Xpert might be used to further increase diagnostic yield in HIVinfected patients [60–63].”
MethodYu, G., Zhong, F., Ye, B., Xu, X., Chen, D., & Shen, Y. (2019) · BioMed Research International · doi:10.1155/2019/4878240 · Cited by 52
Dhooria, S., Gupta, N., Bal, A., Sehgal, I. S., Aggarwal, A. N., Sethi, S. K., Behera, D., & Agarwal, R. (2016) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 44
Epidemiology and Diagnosis of Tuberculous Lymphadenitis in a Tuberculosis Low-Burden Country
Salvador, F., Los-Arcos, I., Sánchez-Montalvá, A., Tórtola, T., Curran, A., Villar, A., Saborit, N., Castellví, J., & Molina, I. (2015) · Medicine · doi:10.1097/md.0000000000000509 · Cited by 43
Ullah, I., Javaid, A., Masud, H., Ali, M., Basit, A., Ahmad, W., Younis, F., Yasmin, R., Khan, A., Jabbar, A., et al. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000449 · Cited by 41
“Sensitivity was 86% in the current study, which is comparable to other published studies [25–31]; however, evidence exists for even higher sensitivity [23, 32, 33].”
ResultWassenberg, M. W. M., Kluytmans, J. A. J. W., Erdkamp, S., Bosboom, R. W., Buiting, A. G. M., van Elzakker, E., Melchers, W. J. G., Thijsen, S. F. T., Troelstra, A., Vandenbroucke‐Grauls, C. M. J. E., et al. (2012) · Critical Care · doi:10.1186/cc11184 · Cited by 41
Gong, X., He, Y., Zhou, K., Hua, Y., & Li, Y. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1149741 · Cited by 50
“characteristics of the 144 included studies from 107 articles (Armand et al., 2011; Causse et al., 2011; Friedrich et al., 2011; Ligthelm et al., 2011; Malbruny et al., 2011; Vadwai et al., 2011; Moure et al., 2012; Tortoli et al., 2012; Bates et al., 2013; Christopher et al., 2013; Porcel et al., 2013; Van Rie et al.…”
BackgroundSarfaraz, S., Iftikhar, S., Memon, Y., Zahir, N., Hereker, F. F., & Salahuddin, N. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.08.020 · Cited by 35
Biadglegne, F., Mulu, A., Rodloff, A. C., & Sack, U. (2014) · Tuberculosis · doi:10.1016/j.tube.2014.05.002 · Cited by 35
Tebruegge, M., Ritz, N., Koetz, K., Noguera‐Julián, A., Seddon, J. A., Welch, S. B., Tsolia, M. N., & Kampmann, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099129 · Cited by 36
“Importantly, while there are data suggesting that the sensitivity of the Xpert MTB/RIF assay is relatively high with CSF and biopsy samples, previous reports have shown the performance to be suboptimal with stool samples, and pleural, peritoneal and joint fluids [24-32].”
BackgroundTuberculosis diagnostics for children in high-burden countries: what is available and what is needed
Cuevas, L. E., Petrucci, R., & Swaminathan, S. (2012) · Paediatrics and International Child Health · doi:10.1179/2046904712z.00000000076 · Cited by 35
Diagnosis of tuberculous lymphadenitis using fine needle aspiration biopsy
Knox, J., Lane, G., Wong, J. S. J., Trevan, P. G., & Karunajeewa, H. (2012) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2012.02748.x · Cited by 31
Rapid Diagnosis of Pediatric Mycobacterial Lymphadenitis Using Fine Needle Aspiration Biopsy
Coetzee, L., Nicol, M. P., Jacobson, R., Schubert, P. T., van Helden, P. D., Warren, R. M., & Wright, C. A. (2014) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000312 · Cited by 29
“The performance of Xpert MTB/RIF in our study was lower than that reported by Ligthelm et al.13 This may be because of potentially lower bacterial load and poorer quality aspirates in pediatric FNAB compared with adult aspirates.”
ResultSelf-citationThe World Health Organization Recommended TB Diagnostic Tools
Zijenah, L. S. (2018) · InTech eBooks · doi:10.5772/intechopen.73070 · Cited by 45
Reddy, D. L., Venter, F., & Pather, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130148 · Cited by 31
New Xpert MTB/XDR: added value and future in the field
Bainomugisa, A., Gilpin, C. M., Coulter, C., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.03616-2020 · Cited by 27
Self-citationFanny, M.-L., Beyam, N., Gody, J. C., Zandanga, G., Yango, F., Manirakiza, A., Rigouts, L., Pierre-Audigier, C., Gicquel, B., & Bobossi, G. (2012) · BMC Pediatrics · doi:10.1186/1471-2431-12-191 · Cited by 25
“management of mycobacterial infection in children [19,20].”
Komanapalli, S. K., Prasad, U. S., Atla, B., Nammi, V., & Yendluri, D. (2018) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20184904 · Cited by 25
Van Rie, A., Page-Shipp, L., Mellet, K., Scott, L., Mkhwnazi, M., Jong, E., Omar, T., Beylis, N., Stevens, W., Sanne, I., et al. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1890-0 · Cited by 24
Mukhida, S. S., Vyawahare, C., Mirza, S. B., Gandham, N. R., Khan, S., Kannuri, S., & Bhaumi, S. (2022) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_86_22 · Cited by 28
“[18], but still lower in comparison to other studies mentioned above [15-17,19,20].”
ResultMarouane, C., Smaoui, S., Kammoun, S., Slim, L., & Messadi-Akrout, F. (2015) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2015.10.012 · Cited by 22
Sharif, N., Ahmed, D., Mahmood, R. T., Qasim, Z., Khan, S. N., Jabbar, A., Khattak, A. A., Asad, M. J., Ahmed, W., Khan, M. M., et al. (2021) · Brazilian Journal of Biology · doi:10.1590/1519-6984.244311 · Cited by 21
“2014; Penz et al., 2015; Ligthelm et al., 2011), while it is almost same to a study (Sarfaraz et al., 2018).”
BackgroundP.G Resident, D. O. P. M., Singh, D. K. G., Tandon, D. S., Professor and Head, D. O. P. M., Nagdeote, D. S. T., Professor, D. O. P. M., Sharma, D. K., Assistant Professor, D. O. P. M., Kumar, D. A., & P.G Resident, D. O. P. M. (2017) · International Journal of Medical Research and Review · doi:10.17511/ijmrr.2017.i03.05 · Cited by 18
“It has been availa ble for nearly two decades and serves as the first-line diagnostic technique in superficial TB lymphadenopathy with sensitivity and specificity of 79% a nd 94% respectively [4].”
BackgroundAkhter, N., Sumalani, K. K., Chawla, D., & Rizvi, N. A. (2019) · ERJ Open Research · doi:10.1183/23120541.00065-2019 · Cited by 19
Nicol, M. P., Whitelaw, A. C., & Stevens, W. S. (2013) · Current Respiratory Medicine Reviews · doi:10.2174/1573398x113099990015 · Cited by 18
“Specificity was high (>98%) in all studies, apart from one small study of lymph node aspirates [36].”
BackgroundSelf-citationPromising directions in the diagnosis of childhood tuberculosis
Whittaker, E., & Zar, H. J. (2012) · Expert Review of Respiratory Medicine · doi:10.1586/ers.12.36 · Cited by 15
Performance of the Roche LightCycler Real-Time PCR Assay for Diagnosing Extrapulmonary Tuberculosis
Gous, N. M., Scott, L. E., Wong, E. B., Omar, T., Venter, F., & Stevens, W. S. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00252-12 · Cited by 16
“The use of lymph node biopsies is safe, well tolerated, and diagnostically relevant for tuberculous lymphadenitis due to the high yield of tissue obtained (11, 15, 32).”
BackgroundMethodTuberculosis revisited: Cytological perspective
Chatterjee, D., & Dey, P. (2014) · Diagnostic Cytopathology · doi:10.1002/dc.23190 · Cited by 16
“It has been showed 97% sensitivity and as high as 99% specificity.(79,80) The turnover time is less than 2 hour compared with average 18.”
BackgroundXpert MTB/RIF for diagnosis of tuberculous cervical lymphadenitis in HIV‐infected patients
Ablanedo‐Terrazas, Y., la Barrera, C. A., Hernández‐Juan, R., Ruiz‐Cruz, M., & Reyes‐Terán, G. (2013) · The Laryngoscope · doi:10.1002/lary.24478 · Cited by 18
“, who previously reported the utility of Xpert for the diagnosis of TB lymphadenitis from FNA biopsy specimens.(15) The elevated rate of cervical TB lymphadenitis in EPTB cases(6) and the high performance of Xpert in lymph node tissue observed here become particularly relevant in resourcelimited settings, where HIV-in…”
BackgroundBennani, K., Khattabi, A., Akrim, M., Mahtar, M., Benmansour, N., Hossyni, L. E., Karkouri, M., Cherradi, N., Messaoudi, M. D. E., Lahlou, O., et al. (2019) · JMIR Public Health and Surveillance · doi:10.2196/14252 · Cited by 20
“The Xpert test was combined with the culture to strengthen the bacteriological gold standard, as its sensitivity (Se) and specificity (Sp), using lymph node biopsies, were, respectively, 96.6% and 88.9% [7].”
InfluentialGene Xpert MTB/RIF Assay: A New Hope for Extrapulmonary Tuberculosis
Raj, A. (2012) · IOSR Journal of Pharmacy (IOSRPHR) · doi:10.9790/3013-02108389 · Cited by 15
Diagnosis of tuberculous lymphadenitis by molecular and immunological tools
Kumar, N., Khan, A., Boora, S., Chadha, N., Khan, N., Raina, P. L., Gupta, R., Singh, R. P., & Kaushik, S. (2024) · Medicine in Microecology · doi:10.1016/j.medmic.2024.100116 · Cited by 14
Meng, X., Fu, H., Jia, W., Wang, Y., & Yang, G. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1022470 · Cited by 12
“If a patient has both TB infection and rifampicin resistance, Xpert then indicates this (26).”
BackgroundChiang, S. S., & Starke, J. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00134-1 · Cited by 17
Drug-Resistant Tuberculosis in Pet Ring-Tailed Lemur, Madagascar
LaFleur, M., Reuter, K. E., Hall, M. B., Rasoanaivo, H. A., McKernan, S., Ranaivomanana, P. P., Michel, A. L., Rabodoarivelo, M. S., Iqbal, Z., Rakotosamimanana, N., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2703.202924 · Cited by 11
Baikunje, N., Behera, D., Rajwanshi, A., Sharma, M., Sharma, A., & Sharma, K. (2019) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2019.101459 · Cited by 10
Siddegowda, M. S., Shivakumar, S., & Mythreyi, M. (2020) · IP Journal of diagnostic pathology and oncology/IP journal of diagnostic pathology and oncology/Journal of diagnostic pathology and oncology · doi:10.18231/j.jdpo.2020.031 · Cited by 8
Mohindra, S., Nayak, H. K., Mohindra, N., Kumar, A., Saraswat, V. A., Kumari, N., Misra, R., & Ghoshal, U. C. (2021) · Indian Journal of Gastroenterology · doi:10.1007/s12664-020-01136-6 · Cited by 9
Kumbi, H., Ali, M. M., & Abate, A. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09554-z · Cited by 7
“[20] and South Africa, 88.9% [23].”
InfluentialChen, Z.-K., Wu, Z., Ye, T., Lin, C.-Y., & Guo, X. (2025) · PLoS ONE · doi:10.1371/journal.pone.0321507 · Cited by 10
“Typically, studies have employed a CRS involving culture, microscopy, or cytology of FNA samples [46,47].”
Mahajan, N. (2020) · US Endocrinology · doi:10.17925/use.2020.16.2.109 · Cited by 7
“Limitations of the test include the presence of similar lesions in conditions like leprosy, systemic lupus erythematous, rheumatoid arthritis, pneumoconiosis, sarcoidosis, fungal infections, and syphilis; which results in a low sensitivity.(14) Non-caseating granulomas may be formed in some organs and bacteriologicall…”
BackgroundБородулина, Е. А., Piskun, V. V., Ураксина, М. В., & Shubina, A. T. (2023) · Russian Clinical Laboratory Diagnostics · doi:10.51620/0869-2084-2022-67-9-544-549 · Cited by 10
Razack, R., Louw, M., & Wright, C. A. (2013) · South African Medical Journal · doi:10.7196/samj.7492 · Cited by 6
Mohan, V. F., Nangia, V., Singh, A., Behl, R., & Dumeer, N. (2021) · Lung India · doi:10.4103/lungindia.lungindia_128_20 · Cited by 6
“few performance data have been published to date on nonrespiratory specimens.[16-22] We previously”
BackgroundPatil, S., Dhage, S., Umap, P. S., Ghorpade, S. V., & Patharwat, S. (2020) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20201465 · Cited by 12
Hueda-Zavaleta, M., de la Torre, J. C. G., Carrillo, C. F. B., Flores-Flores, C., Piscoche, C., Miranda-Visalot, C., Mendoza, A., Gomez-Colque, S., Taype-Rondán, Á., & Corzo, C. A. C. (2024) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2024.101730 · Cited by 11
Sidiq, Z., Hanif, M., Dwivedi, K. K., Chopra, K. K., Khanna, A. K., & Vashishat, B. K. (2021) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2021.08.011 · Cited by 5
Evaluation of Xpert MTB/RIF for the Diagnosis of Lymphatic Tuberculosis
Li, H., He, Z., Liang, J., Li, G., Xie, T., Liu, Y., Li, Z., Feng, X., Xia, Y., & Guo, X. (2020) · BioMed Research International · doi:10.1155/2020/1968487 · Cited by 4
“(b) [11] 2011 Retrospective CRS 28 3 1 16 FNA 0”
Chiang, S. S., & Starke, J. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00134-8 · Cited by 5
Kilfoil, K. M., Mayne, E. S., Scott, L. E., & Stevens, W. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134404 · Cited by 5
Ahmed, S., Ansari, H. A., & Fatima, N. (2022) · International Journal of Health Sciences and Research · doi:10.52403/ijhsr.20220127 · Cited by 3
Mukherjee, S., Biswas, D., Begum, S., Ghosh, P., Pal, A., & Sarkar, S. (2021) · International Journal of Current Research and Review · doi:10.31782/ijcrr.2021.13618 · Cited by 3
Madhusudan, M., Potti, P., Mohite, K., Chandra, T., & Srikanta, J. T. (2025) · Lung India · doi:10.4103/lungindia.lungindia_288_24 · Cited by 4
Tuberculosis in Lemurs and a Fossa at National Zoo, Madagascar, 2022
LaFleur, M., Rasoanaivo, H. A., Andrianarivo, T. H., Andrianomanana, F. R., McKernan, S., Raherison, M. S., Rakotoson, A., Miller, M. A., Ratsimbazafy, J., Lapierre, S. G., et al. (2023) · Emerging infectious diseases · doi:10.3201/eid2912.231159 · Cited by 3
Genexpert technology: A new ray of hope for the diagnosis of tuberculour pericardial effusion
Das, B., & Negi, N. (2015) · Journal of the Practice of Cardiovascular Sciences · doi:10.4103/2395-5414.177230 · Cited by 3
Diagnosis of lymph node tuberculosis using the GeneXpert MTB/RIF in Bangladesh
Nur, T., Hosna, A., Rayhan, N., & Nazneen, N. (2018) · Mediscope · doi:10.3329/mediscope.v6i1.38939 · Cited by 3
Vankayala, V. R., Sutrave, S., Kumari, B. S., Gaddam, R., & Mandapakala, G. K. M. (2024) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1284_23 · Cited by 4
“[21] reported 18.5 days as the average.”
InfluentialSumayya, S., Durga, K., S, N. B., Fatima, S., & Krishnaiah, A. (2019) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2019/765 · Cited by 2
Boinwad, A., & Iravane, J. (2021) · ACTA SCIENTIFIC MICROBIOLOGY · doi:10.31080/asmi.2021.04.0937 · Cited by 2
Transforming TB Diagnosis: Can Patients and Control Programs Afford to Wait?
Talbot, E. A., Pape, J. W., Sundaram, L., Boehme, C. C., & Perkins, M. D. (2012) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.12-0247 · Cited by 2
Shetye, S., Chheda, P., Lad, A., & Matkar, S. (2017) · SAARC Journal of Tuberculosis Lung Diseases and HIV/AIDS · doi:10.3126/saarctb.v14i1.17720 · Cited by 2
A., D. K. J., M, D. N., Pandit, G. A., & Londhe, S. S. (2019) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/0501372 · Cited by 2
Ahmed, S., Ansari, H. A., & Fatima, N. (2022) · IP Journal of diagnostic pathology and oncology/IP journal of diagnostic pathology and oncology/Journal of diagnostic pathology and oncology · doi:10.18231/j.jdpo.2022.005 · Cited by 5
Prevalence study of tuberculosis among basrah population through 2011-2015 : prospective study
Alsaimary, I. E. (2019) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1294/6/062087 · Cited by 2
Evaluation of Recurrent Lymphadenitis after Six Months Anti-Tuberculous Therapy
Chowdhury, M. M. H., Chowdhury, M. A. J., Kamal, S. M. M., Anam, M. K., Khan, M., & Zohura, F. T. (2023) · Journal of Bangladesh College of Physicians and Surgeons · doi:10.3329/jbcps.v41i4.68925 · Cited by 1
“15 But, GeneXpert cannot differentiate between live and dead bacilli.”
BackgroundGupta, H., Mehra, D. V., Sharma, R., Singh, S., & Bagga, P. K. (2020) · International Journal of Clinical and Diagnostic Pathology · doi:10.33545/pathol.2020.v3.i1d.180 · Cited by 1
Tuberculosis research in South Africa over the past 30 years: From bench to bedside
Warren, R. M., Ismail, N. A., Chegou, N. N., Theron, G., Walzl, G., Malherbe, S. T., Kinnear, C. J., van der Spuy, G. D., Goosen, W. J., Miller, M. A., et al. (2019) · South African Medical Journal · doi:10.7196/samj.2019.v109i11b.14249 · Cited by 1
“─ EBA and pharmacokinetics of PA-824 in smear-positive TB patients[33] ─ Xpert MTB/RIF rapid diagnosis of lymphadenitis[34] ─ Impact of age and sex on mycobacterial immunity in an area of high TB incidence[35] ─ QuantiFERON-TB Gold (In-Tube) assay modification for M.”
MethodSelf-citationYoo, S., Abebe, G., Yoo, J. M., Regassa, D., & Bezabih, M. (2021) · African Journal of Thoracic and Critical Care Medicine · doi:10.7196/ajtccm.2021.v27i1.120 · Cited by 1
“7%.[2,3] Tuberculous pleuritis (TBP) is a common form of extrapulmonary tuberculosis.”
BackgroundCorrelation of Cytomorphology Pattern in Tuberculous Lymphadenitis with Microbiological Studies.
Khatib, Y., Sheldon, V. G., Chaudhari, J., Gupte, P., Khare, M., Sable, Y., Patel, R., & Shah, V. (2025) · Journal of The Association of Physicians of India · doi:10.59556/japi.73.0871
Sosa, H., Vera, R. N., Valdivia, J. L. P., et al. (2014) · Revista Médica Herediana · doi:10.20453/rmh.v25i2.253
Ngabonziza, J. C. S. (2014) · University of Nairobi Research Archive (University of Nairobi)
Jetley, S., Jairajpuri, Z., Pujani, M., & Khan, S. (2016) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20161818 · Cited by 1
LYMPH NODE TUBERCULOSIS- CURRENT SCENARIO
Glory, D. N., & Muthulakshmi, N. (2018) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2018/311 · Cited by 1
Metadata
- Authors
- Ligthelm, L. J., Nicol, M. P., Hoek, K. G. P., Jacobson, R., van Helden, P. D., Marais, B. J., Warren, R. M., & Wright, C. A.
- Affiliations
- National Health Laboratory Service (ZA)
- DST/NRF Centre of Excellence for Biomedical Tuberculosis Research/MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics of the Department of Biomedical Sciences, Faculty of Health Sciences Stellenbosch University, Tygerberg, Cape Town, South Africa
- The University of Sydney (AU)
- Stellenbosch University (ZA)
- Corresponding author
- Ligthelm, Louis J.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2011-11
- Volume
- 49
- Issue
- 11
- Pages
- 3967-3970
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC3209093
- OpenAlex
- W2171353099
- Cited by
- 123
- References
- 16
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 5 · 2023: 8 · 2022: 7 · 2021: 15 · 2020: 9 · 2019: 11 · 2018: 6 · 2017: 6 · 2016: 3 · 2015: 8 · 2014: 15 · 2013: 7 · 2012: 15
- FWCI
- 7.99
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- SUNScholar (Stellenbosch University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Keywords
- Xpert MTB/RIF, tuberculous lymphadenitis, Mycobacterium tuberculosis, rapid molecular diagnostics, fine-needle aspiration, diagnostic accuracy, sensitivity and specificity, rifampicin resistance, smear-negative tuberculosis, culture-positive tuberculosis
- MeSH terms
- Adolescent, Adult, Antitubercular Agents, Bacteriological Techniques, Child, Child, Preschool, Female, Humans, Male, Mycobacterium tuberculosis, Reagent Kits, Diagnostic, Rifampin, Sensitivity and Specificity, Tuberculosis, Lymph Node, Drug Resistance, Bacterial, Molecular Diagnostic Techniques, Biopsy, Fine-Needle, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.